Suppr超能文献

尿毒症的透析治疗与移植:何时选用何种治疗方法。

Dialysis therapy and transplantation in uremia: which to use when.

作者信息

Shinaberger J H, Blumenkrantz M J

出版信息

Postgrad Med. 1978 Nov;64(5):169-79. doi: 10.1080/00325481.1978.11714979.

Abstract

In the United States, 10,000 to 18,000 new patients require therapy for end-stage renal disease each year. A combination of medical and psychosocial criteria can be used to predict whether renal transplantation or maintenance hemodialysis or peritoneal dialysis may be the most efficacious treatment. In most cases, dialysis therapy should be initiated when signs and symptoms of uremia are only subtle, usually when creatinine clearance is between 3 and 6 ml/min. One mode of therapy can be exchanged for another to suit changing needs, and vascular access should be created even in patients who ultimately will undergo peritoneal dialysis or receive a transplant.

摘要

在美国,每年有10000至18000名新患者需要接受终末期肾病治疗。医学标准和社会心理标准相结合可用于预测肾移植、维持性血液透析或腹膜透析哪种可能是最有效的治疗方法。在大多数情况下,当尿毒症的体征和症状尚不明显时,通常是肌酐清除率在3至6毫升/分钟之间时,就应开始透析治疗。一种治疗方式可根据不断变化的需求换成另一种,即使是最终要接受腹膜透析或接受移植的患者,也应建立血管通路。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验